CR MEDICAL (01515) has announced its interim results for the six months ended June 30, 2026, revealing a challenging period marked by a decrease in profitability despite relatively stable revenue generation.

According to the financial report, the group recorded revenue of RMB 4.479 billion, reflecting a modest year-on-year decline of 1.02%. However, profit attributable to shareholders amounted to RMB 265 million, representing a significant drop of 21.98% compared to the corresponding period last year. Basic earnings per share stood at RMB 0.21, and the board has proposed an interim dividend of RMB 0.05 per share.

In terms of operational performance, the hospital business segment achieved turnover of RMB 4.317 billion during the reporting period, marking a year-on-year increase of 1.4%. The outpatient and emergency department visits grew by 5.2%, while inpatient admissions saw a modest rise of 0.3%. Notably, the average revenue per outpatient and emergency visit declined by 6.1%, whereas the average revenue per inpatient visit increased by 3.1%.

As of June 30, 2026, the group managed and operated a total of 90 medical institutions across 10 provinces and cities in China. During the reporting period, the group's self-owned hospitals handled approximately 5.37 million outpatient and emergency visits and 270,000 inpatient admissions, representing year-on-year growth of 5.2% and 0.3%, respectively.